---
title:  "Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19"
categories: studies
permalink: 20200507b.html
tags: [negative]
---

[source](https://ard.bmj.com/content/early/2020/05/20/annrheumdis-2020-217690.full)

## Summary

Thus, patients with lupus—even if they are using an antimalarial such as HCQ as baseline therapy—can develop SARS-CoV-2 infection and severe COVID-19 at similar frequency as lupus patients not on antimalarials.

{% include links.html %}
